Skip to main content
Top
Published in: Molecular Neurodegeneration 1/2012

Open Access 01-12-2012 | Research article

LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors

Authors: Kelly M Hinkle, Mei Yue, Bahareh Behrouz, Justus C Dächsel, Sarah J Lincoln, Erin E Bowles, Joel E Beevers, Brittany Dugger, Beate Winner, Iryna Prots, Caroline B Kent, Kenya Nishioka, Wen-Lang Lin, Dennis W Dickson, Christopher J Janus, Matthew J Farrer, Heather L Melrose

Published in: Molecular Neurodegeneration | Issue 1/2012

Login to get access

Abstract

Mutations in the LRRK2 gene are the most common cause of genetic Parkinson’s disease. Although the mechanisms behind the pathogenic effects of LRRK2 mutations are still not clear, data emerging from in vitro and in vivo models suggests roles in regulating neuronal polarity, neurotransmission, membrane and cytoskeletal dynamics and protein degradation.
We created mice lacking exon 41 that encodes the activation hinge of the kinase domain of LRRK2. We have performed a comprehensive analysis of these mice up to 20 months of age, including evaluation of dopamine storage, release, uptake and synthesis, behavioral testing, dendritic spine and proliferation/neurogenesis analysis.
Our results show that the dopaminergic system was not functionally comprised in LRRK2 knockout mice. However, LRRK2 knockout mice displayed abnormal exploratory activity in the open-field test. Moreover, LRRK2 knockout mice stayed longer than their wild type littermates on the accelerated rod during rotarod testing. Finally, we confirm that loss of LRRK2 caused degeneration in the kidney, accompanied by a progressive enhancement of autophagic activity and accumulation of autofluorescent material, but without evidence of biphasic changes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zimprich A, et al: Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron. 2004, 44: 601-607. 10.1016/j.neuron.2004.11.005.CrossRefPubMed Zimprich A, et al: Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron. 2004, 44: 601-607. 10.1016/j.neuron.2004.11.005.CrossRefPubMed
2.
go back to reference Paisan-Ruiz C, Evans EW, Jain S, Xiromerisiou G, Gibbs JR, Eerola J, Gourbali V, Hellstrom O, Duckworth J, Papadimitriou A, Tienari PJ, Hadjigeorgiou GM, Singleton AB: Testing association between LRRK2 and Parkinson's disease and investigating linkage disequilibrium. J Med Genet. 2006, 43: e9-PubMedCentralCrossRefPubMed Paisan-Ruiz C, Evans EW, Jain S, Xiromerisiou G, Gibbs JR, Eerola J, Gourbali V, Hellstrom O, Duckworth J, Papadimitriou A, Tienari PJ, Hadjigeorgiou GM, Singleton AB: Testing association between LRRK2 and Parkinson's disease and investigating linkage disequilibrium. J Med Genet. 2006, 43: e9-PubMedCentralCrossRefPubMed
3.
go back to reference Kachergus J, Mata IF, Hulihan M, Taylor JP, Lincoln S, Aasly J, Gibson JM, Ross OA, Lynch T, Wiley J, Payami H, Nutt J, Maraganore DM, Czyzewski K, Styczynska M, Wszolek ZK, Farrer MJ, Toft M: Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. Am J Hum Genet. 2005, 76: 672-680. 10.1086/429256.PubMedCentralCrossRefPubMed Kachergus J, Mata IF, Hulihan M, Taylor JP, Lincoln S, Aasly J, Gibson JM, Ross OA, Lynch T, Wiley J, Payami H, Nutt J, Maraganore DM, Czyzewski K, Styczynska M, Wszolek ZK, Farrer MJ, Toft M: Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. Am J Hum Genet. 2005, 76: 672-680. 10.1086/429256.PubMedCentralCrossRefPubMed
4.
go back to reference Ozelius LJ, Senthil G, Saunders-Pullman R, Ohmann E, Deligtisch A, Tagliati M, Hunt AL, Klein C, Henick B, Hailpern SM, Lipton RB, Soto-Valencia J, Risch N, Bressman SB: LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N Engl J Med. 2006, 354: 424-425. 10.1056/NEJMc055509.CrossRefPubMed Ozelius LJ, Senthil G, Saunders-Pullman R, Ohmann E, Deligtisch A, Tagliati M, Hunt AL, Klein C, Henick B, Hailpern SM, Lipton RB, Soto-Valencia J, Risch N, Bressman SB: LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N Engl J Med. 2006, 354: 424-425. 10.1056/NEJMc055509.CrossRefPubMed
5.
go back to reference Ishihara L, et al: Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families. Mov Disord. 2007, 22: 55-61. 10.1002/mds.21180.CrossRefPubMed Ishihara L, et al: Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families. Mov Disord. 2007, 22: 55-61. 10.1002/mds.21180.CrossRefPubMed
6.
go back to reference Di Fonzo A, Wu-Chou YH, Lu CS, van Doeselaar M, Simons EJ, Rohe CF, Chang HC, Chen RS, Weng YH, Vanacore N, Breedveld GJ, Oostra BA, Bonifati V: A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan. Neurogenetics. 2006, 7: 133-138. 10.1007/s10048-006-0041-5.CrossRefPubMed Di Fonzo A, Wu-Chou YH, Lu CS, van Doeselaar M, Simons EJ, Rohe CF, Chang HC, Chen RS, Weng YH, Vanacore N, Breedveld GJ, Oostra BA, Bonifati V: A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan. Neurogenetics. 2006, 7: 133-138. 10.1007/s10048-006-0041-5.CrossRefPubMed
7.
go back to reference Tan EK: Identification of a common genetic risk variant (LRRK2 Gly2385Arg) in Parkinson's disease. Ann Acad Med Singapore. 2006, 35: 840-842.PubMed Tan EK: Identification of a common genetic risk variant (LRRK2 Gly2385Arg) in Parkinson's disease. Ann Acad Med Singapore. 2006, 35: 840-842.PubMed
8.
go back to reference Farrer MJ, Stone JT, Lin CH, Dachsel JC, Hulihan MM, Haugarvoll K, Ross OA, Wu RM: Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia. Parkinsonism & related disorders. 2007, 13: 89-92. 10.1016/j.parkreldis.2006.12.001.CrossRef Farrer MJ, Stone JT, Lin CH, Dachsel JC, Hulihan MM, Haugarvoll K, Ross OA, Wu RM: Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia. Parkinsonism & related disorders. 2007, 13: 89-92. 10.1016/j.parkreldis.2006.12.001.CrossRef
9.
go back to reference Ross OA, Wu YR, Lee MC, Funayama M, Chen ML, Soto AI, Mata IF, Lee-Chen GJ, Chen CM, Tang M, Zhao Y, Hattori N, Farrer MJ, Tan EK, Wu RM: Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease. Ann Neurol. 2008, 64: 88-92. 10.1002/ana.21405.CrossRefPubMed Ross OA, Wu YR, Lee MC, Funayama M, Chen ML, Soto AI, Mata IF, Lee-Chen GJ, Chen CM, Tang M, Zhao Y, Hattori N, Farrer MJ, Tan EK, Wu RM: Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease. Ann Neurol. 2008, 64: 88-92. 10.1002/ana.21405.CrossRefPubMed
10.
go back to reference Daniels V, Baekelandt V, Taymans JM: On the road to leucine-rich repeat kinase 2 signalling: evidence from cellular and in vivo studies. Neurosignals. 2011, 19: 1-15. 10.1159/000324488.CrossRefPubMed Daniels V, Baekelandt V, Taymans JM: On the road to leucine-rich repeat kinase 2 signalling: evidence from cellular and in vivo studies. Neurosignals. 2011, 19: 1-15. 10.1159/000324488.CrossRefPubMed
11.
go back to reference Yue Z, Lachenmayer ML: Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applications. Mov Disord. 2011, 26: 1386-1397. 10.1002/mds.23737.PubMedCentralCrossRefPubMed Yue Z, Lachenmayer ML: Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applications. Mov Disord. 2011, 26: 1386-1397. 10.1002/mds.23737.PubMedCentralCrossRefPubMed
12.
go back to reference Nandhagopal R, Mak E, Schulzer M, McKenzie J, McCormick S, Sossi V, Ruth TJ, Strongosky A, Farrer MJ, Wszolek ZK, Stoessl AJ: Progression of dopaminergic dysfunction in a LRRK2 kindred: a multitracer PET study. Neurology. 2008, 71: 1790-1795. 10.1212/01.wnl.0000335973.66333.58.PubMedCentralCrossRefPubMed Nandhagopal R, Mak E, Schulzer M, McKenzie J, McCormick S, Sossi V, Ruth TJ, Strongosky A, Farrer MJ, Wszolek ZK, Stoessl AJ: Progression of dopaminergic dysfunction in a LRRK2 kindred: a multitracer PET study. Neurology. 2008, 71: 1790-1795. 10.1212/01.wnl.0000335973.66333.58.PubMedCentralCrossRefPubMed
13.
go back to reference Sossi V, de la Fuente-Fernandez R, Nandhagopal R, Schulzer M, McKenzie J, Ruth TJ, Aasly JO, Farrer MJ, Wszolek ZK, Stoessl JA: Dopamine turnover increases in asymptomatic LRRK2 mutations carriers. Mov Disord. 2010, 25: 2717-2723. 10.1002/mds.23356.CrossRefPubMed Sossi V, de la Fuente-Fernandez R, Nandhagopal R, Schulzer M, McKenzie J, Ruth TJ, Aasly JO, Farrer MJ, Wszolek ZK, Stoessl JA: Dopamine turnover increases in asymptomatic LRRK2 mutations carriers. Mov Disord. 2010, 25: 2717-2723. 10.1002/mds.23356.CrossRefPubMed
14.
go back to reference Bostantjopoulou S, Katsarou Z, Gerasimou G, Costa DC, Gotzamani-Psarrakou A: (123)I-FP-CIT SPET striatal uptake in parkinsonian patients with the alpha-synuclein (G209A) mutation A. Hell J Nucl Med. 2008, 11: 157-159.PubMed Bostantjopoulou S, Katsarou Z, Gerasimou G, Costa DC, Gotzamani-Psarrakou A: (123)I-FP-CIT SPET striatal uptake in parkinsonian patients with the alpha-synuclein (G209A) mutation A. Hell J Nucl Med. 2008, 11: 157-159.PubMed
15.
go back to reference Perani D, Garibotto V, Hadjigeorgiou GM, Papadimitriou D, Fazio F, Papadimitriou A: Positron emission tomography changes in PARK1 mutation. Mov Disord. 2006, 21: 127-130. 10.1002/mds.20691.CrossRefPubMed Perani D, Garibotto V, Hadjigeorgiou GM, Papadimitriou D, Fazio F, Papadimitriou A: Positron emission tomography changes in PARK1 mutation. Mov Disord. 2006, 21: 127-130. 10.1002/mds.20691.CrossRefPubMed
16.
go back to reference Samii A, Markopoulou K, Wszolek ZK, Sossi V, Dobko T, Mak E, Calne DB, Stoessl AJ: PET studies of parkinsonism associated with mutation in the alpha-synuclein gene. Neurology. 1999, 53: 2097-2102. 10.1212/WNL.53.9.2097.CrossRefPubMed Samii A, Markopoulou K, Wszolek ZK, Sossi V, Dobko T, Mak E, Calne DB, Stoessl AJ: PET studies of parkinsonism associated with mutation in the alpha-synuclein gene. Neurology. 1999, 53: 2097-2102. 10.1212/WNL.53.9.2097.CrossRefPubMed
17.
go back to reference Biskup S, Moore DJ, Rea A, Lorenz-Deperieux B, Coombes CE, Dawson VL, Dawson TM, West AB: Dynamic and redundant regulation of LRRK2 and LRRK1 expression. BMC Neurosci. 2007, 8: 102-10.1186/1471-2202-8-102.PubMedCentralCrossRefPubMed Biskup S, Moore DJ, Rea A, Lorenz-Deperieux B, Coombes CE, Dawson VL, Dawson TM, West AB: Dynamic and redundant regulation of LRRK2 and LRRK1 expression. BMC Neurosci. 2007, 8: 102-10.1186/1471-2202-8-102.PubMedCentralCrossRefPubMed
18.
go back to reference Biskup S, Moore DJ, Celsi F, Higashi S, West AB, Andrabi SA, Kurkinen K, Yu SW, Savitt JM, Waldvogel HJ, Faull RL, Emson PC, Torp R, Ottersen OP, Dawson TM, Dawson VL: Localization of LRRK2 to membranous and vesicular structures in mammalian brain. Ann Neurol. 2006, 60: 557-569. 10.1002/ana.21019.CrossRefPubMed Biskup S, Moore DJ, Celsi F, Higashi S, West AB, Andrabi SA, Kurkinen K, Yu SW, Savitt JM, Waldvogel HJ, Faull RL, Emson PC, Torp R, Ottersen OP, Dawson TM, Dawson VL: Localization of LRRK2 to membranous and vesicular structures in mammalian brain. Ann Neurol. 2006, 60: 557-569. 10.1002/ana.21019.CrossRefPubMed
19.
go back to reference Galter D, Westerlund M, Carmine A, Lindqvist E, Sydow O, Olson L: LRRK2 expression linked to dopamine-innervated areas. Ann Neurol. 2006, 59: 714-719. 10.1002/ana.20808.CrossRefPubMed Galter D, Westerlund M, Carmine A, Lindqvist E, Sydow O, Olson L: LRRK2 expression linked to dopamine-innervated areas. Ann Neurol. 2006, 59: 714-719. 10.1002/ana.20808.CrossRefPubMed
20.
go back to reference Melrose H, Lincoln S, Tyndall G, Dickson D, Farrer M: Anatomical localization of leucine-rich repeat kinase 2 in mouse brain. Neuroscience. 2006, 139: 791-794. 10.1016/j.neuroscience.2006.01.017.CrossRefPubMed Melrose H, Lincoln S, Tyndall G, Dickson D, Farrer M: Anatomical localization of leucine-rich repeat kinase 2 in mouse brain. Neuroscience. 2006, 139: 791-794. 10.1016/j.neuroscience.2006.01.017.CrossRefPubMed
21.
go back to reference Simon-Sanchez J, Herranz-Perez V, Olucha-Bordonau F, Perez-Tur J: LRRK2 is expressed in areas affected by Parkinson's disease in the adult mouse brain. Eur J Neurosci. 2006, 23: 659-666. 10.1111/j.1460-9568.2006.04616.x.CrossRefPubMed Simon-Sanchez J, Herranz-Perez V, Olucha-Bordonau F, Perez-Tur J: LRRK2 is expressed in areas affected by Parkinson's disease in the adult mouse brain. Eur J Neurosci. 2006, 23: 659-666. 10.1111/j.1460-9568.2006.04616.x.CrossRefPubMed
22.
go back to reference Taymans JM, Van den Haute C, Baekelandt V: Distribution of PINK1 and LRRK2 in rat and mouse brain. J Neurochem. 2006, 98: 951-961. 10.1111/j.1471-4159.2006.03919.x.CrossRefPubMed Taymans JM, Van den Haute C, Baekelandt V: Distribution of PINK1 and LRRK2 in rat and mouse brain. J Neurochem. 2006, 98: 951-961. 10.1111/j.1471-4159.2006.03919.x.CrossRefPubMed
23.
go back to reference Melrose HL, Kent CB, Taylor JP, Dachsel JC, Hinkle KM, Lincoln SJ, Mok SS, Culvenor JG, Masters CL, Tyndall GM, Bass DI, Ahmed Z, Andorfer CA, Ross OA, Wszolek ZK, Delldonne A, Dickson DW, Farrer MJ: A comparative analysis of leucine-rich repeat kinase 2 (Lrrk2) expression in mouse brain and Lewy body disease. Neuroscience. 2007, 147: 1047-1058. 10.1016/j.neuroscience.2007.05.027.CrossRefPubMed Melrose HL, Kent CB, Taylor JP, Dachsel JC, Hinkle KM, Lincoln SJ, Mok SS, Culvenor JG, Masters CL, Tyndall GM, Bass DI, Ahmed Z, Andorfer CA, Ross OA, Wszolek ZK, Delldonne A, Dickson DW, Farrer MJ: A comparative analysis of leucine-rich repeat kinase 2 (Lrrk2) expression in mouse brain and Lewy body disease. Neuroscience. 2007, 147: 1047-1058. 10.1016/j.neuroscience.2007.05.027.CrossRefPubMed
24.
go back to reference Shi WX, Pun CL, Smith PL, Bunney BS: Endogenous DA-mediated feedback inhibition of DA neurons: involvement of both D(1)- and D(2)-like receptors. Synapse. 2000, 35: 111-119. 10.1002/(SICI)1098-2396(200002)35:2<111::AID-SYN3>3.0.CO;2-7.CrossRefPubMed Shi WX, Pun CL, Smith PL, Bunney BS: Endogenous DA-mediated feedback inhibition of DA neurons: involvement of both D(1)- and D(2)-like receptors. Synapse. 2000, 35: 111-119. 10.1002/(SICI)1098-2396(200002)35:2<111::AID-SYN3>3.0.CO;2-7.CrossRefPubMed
25.
go back to reference Dachsel JC, Behrouz B, Yue M, Beevers JE, Melrose HL, Farrer MJ: A comparative study of Lrrk2 function in primary neuronal cultures. Parkinsonism Relat Disord. 2010, 16: 650-655. 10.1016/j.parkreldis.2010.08.018.PubMedCentralCrossRefPubMed Dachsel JC, Behrouz B, Yue M, Beevers JE, Melrose HL, Farrer MJ: A comparative study of Lrrk2 function in primary neuronal cultures. Parkinsonism Relat Disord. 2010, 16: 650-655. 10.1016/j.parkreldis.2010.08.018.PubMedCentralCrossRefPubMed
26.
go back to reference Winner B, Melrose HL, Zhao C, Hinkle KM, Yue M, Kent C, Braithwaite AT, Ogholikhan S, Aigner R, Winkler J, Farrer MJ, Gage FH: Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice. Neurobiol Dis. 2011, 41: 706-716. 10.1016/j.nbd.2010.12.008.PubMedCentralCrossRefPubMed Winner B, Melrose HL, Zhao C, Hinkle KM, Yue M, Kent C, Braithwaite AT, Ogholikhan S, Aigner R, Winkler J, Farrer MJ, Gage FH: Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice. Neurobiol Dis. 2011, 41: 706-716. 10.1016/j.nbd.2010.12.008.PubMedCentralCrossRefPubMed
27.
go back to reference Parisiadou L, Xie C, Cho HJ, Lin X, Gu XL, Long CX, Lobbestael E, Baekelandt V, Taymans JM, Sun L, Cai H: Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis. J Neurosci. 2009, 29: 13971-13980. 10.1523/JNEUROSCI.3799-09.2009.PubMedCentralCrossRefPubMed Parisiadou L, Xie C, Cho HJ, Lin X, Gu XL, Long CX, Lobbestael E, Baekelandt V, Taymans JM, Sun L, Cai H: Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis. J Neurosci. 2009, 29: 13971-13980. 10.1523/JNEUROSCI.3799-09.2009.PubMedCentralCrossRefPubMed
28.
go back to reference Parisiadou L, Cai H: LRRK2 function on actin and microtubule dynamics in Parkinson disease. Commun Integr Biol. 2010, 3: 396-400. 10.4161/cib.3.5.12286.PubMedCentralCrossRefPubMed Parisiadou L, Cai H: LRRK2 function on actin and microtubule dynamics in Parkinson disease. Commun Integr Biol. 2010, 3: 396-400. 10.4161/cib.3.5.12286.PubMedCentralCrossRefPubMed
29.
go back to reference Chan D, Citro A, Cordy JM, Shen GC, Wolozin B: Rac1 protein rescues neurite retraction caused by G2019S leucine-rich repeat kinase 2 (LRRK2). J Biol Chem. 2011, 286: 16140-16149. 10.1074/jbc.M111.234005.PubMedCentralCrossRefPubMed Chan D, Citro A, Cordy JM, Shen GC, Wolozin B: Rac1 protein rescues neurite retraction caused by G2019S leucine-rich repeat kinase 2 (LRRK2). J Biol Chem. 2011, 286: 16140-16149. 10.1074/jbc.M111.234005.PubMedCentralCrossRefPubMed
30.
go back to reference Kicka S, Shen Z, Annesley SJ, Fisher PR, Lee S, Briggs S, Firtel RA: The LRRK2-related Roco kinase Roco2 is regulated by Rab1A and controls the actin cytoskeleton. Mol Biol Cell. 2011, 22: 2198-2211. 10.1091/mbc.E10-12-0937.PubMedCentralCrossRefPubMed Kicka S, Shen Z, Annesley SJ, Fisher PR, Lee S, Briggs S, Firtel RA: The LRRK2-related Roco kinase Roco2 is regulated by Rab1A and controls the actin cytoskeleton. Mol Biol Cell. 2011, 22: 2198-2211. 10.1091/mbc.E10-12-0937.PubMedCentralCrossRefPubMed
31.
go back to reference Meixner A, Boldt K, Van Troys M, Askenazi M, Gloeckner CJ, Bauer M, Marto JA, Ampe C, Kinkl N, Ueffing M: A QUICK screen for Lrrk2 interaction partners–leucine-rich repeat kinase 2 is involved in actin cytoskeleton dynamics. Mol Cell Proteomics. 2011, 10 (M110): 001172-PubMed Meixner A, Boldt K, Van Troys M, Askenazi M, Gloeckner CJ, Bauer M, Marto JA, Ampe C, Kinkl N, Ueffing M: A QUICK screen for Lrrk2 interaction partners–leucine-rich repeat kinase 2 is involved in actin cytoskeleton dynamics. Mol Cell Proteomics. 2011, 10 (M110): 001172-PubMed
32.
go back to reference Jedynak JP, Uslaner JM, Esteban JA, Robinson TE: Methamphetamine-induced structural plasticity in the dorsal striatum. Eur J Neurosci. 2007, 25: 847-853. 10.1111/j.1460-9568.2007.05316.x.CrossRefPubMed Jedynak JP, Uslaner JM, Esteban JA, Robinson TE: Methamphetamine-induced structural plasticity in the dorsal striatum. Eur J Neurosci. 2007, 25: 847-853. 10.1111/j.1460-9568.2007.05316.x.CrossRefPubMed
33.
go back to reference Couillard-Despres S, Winner B, Schaubeck S, Aigner R, Vroemen M, Weidner N, Bogdahn U, Winkler J, Kuhn HG, Aigner L: Doublecortin expression levels in adult brain reflect neurogenesis. Eur J Neurosci. 2005, 21: 1-14. 10.1111/j.1460-9568.2004.03813.x.CrossRefPubMed Couillard-Despres S, Winner B, Schaubeck S, Aigner R, Vroemen M, Weidner N, Bogdahn U, Winkler J, Kuhn HG, Aigner L: Doublecortin expression levels in adult brain reflect neurogenesis. Eur J Neurosci. 2005, 21: 1-14. 10.1111/j.1460-9568.2004.03813.x.CrossRefPubMed
34.
go back to reference Tong Y, Yamaguchi H, Giaime E, Boyle S, Kopan R, Kelleher RJ, Shen J: Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice. Proc Natl Acad Sci U S A. 2010, 107: 9879-9884. 10.1073/pnas.1004676107.PubMedCentralCrossRefPubMed Tong Y, Yamaguchi H, Giaime E, Boyle S, Kopan R, Kelleher RJ, Shen J: Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice. Proc Natl Acad Sci U S A. 2010, 107: 9879-9884. 10.1073/pnas.1004676107.PubMedCentralCrossRefPubMed
35.
go back to reference Hall C, Ballachey EL: A Study of the Rat's behavior in a field: A Contribution to Method in Comparative Psychology. Univ Calif Publ Psych. 1932, 6: 1-12. Hall C, Ballachey EL: A Study of the Rat's behavior in a field: A Contribution to Method in Comparative Psychology. Univ Calif Publ Psych. 1932, 6: 1-12.
36.
go back to reference Corman CD, Shafer JN: Open-field activity and exploratory behavior. Psychonomic Science. 1968, 13: 55-56.CrossRef Corman CD, Shafer JN: Open-field activity and exploratory behavior. Psychonomic Science. 1968, 13: 55-56.CrossRef
37.
go back to reference Royce JR: On the construct validity of open-field measures. Psychological Bulletin. 1977, 84: 1098-1106.CrossRef Royce JR: On the construct validity of open-field measures. Psychological Bulletin. 1977, 84: 1098-1106.CrossRef
38.
go back to reference Lauterbach EC, Duvoisin RC: Anxiety disorders in familial parkinsonism. Am J Psychiatry. 1991, 148: 274-PubMed Lauterbach EC, Duvoisin RC: Anxiety disorders in familial parkinsonism. Am J Psychiatry. 1991, 148: 274-PubMed
39.
go back to reference Nilsson FM, Kessing LV, Bolwig TG: Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study. Acta Psychiatr Scand. 2001, 104: 380-386. 10.1034/j.1600-0447.2001.00372.x.CrossRefPubMed Nilsson FM, Kessing LV, Bolwig TG: Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study. Acta Psychiatr Scand. 2001, 104: 380-386. 10.1034/j.1600-0447.2001.00372.x.CrossRefPubMed
40.
go back to reference Zhu XR, Maskri L, Herold C, Bader V, Stichel CC, Gunturkun O, Lubbert H: Non-motor behavioural impairments in parkin-deficient mice. Eur J Neurosci. 2007, 26: 1902-1911. 10.1111/j.1460-9568.2007.05812.x.CrossRefPubMed Zhu XR, Maskri L, Herold C, Bader V, Stichel CC, Gunturkun O, Lubbert H: Non-motor behavioural impairments in parkin-deficient mice. Eur J Neurosci. 2007, 26: 1902-1911. 10.1111/j.1460-9568.2007.05812.x.CrossRefPubMed
41.
go back to reference Treit D, Fundytus M: Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol Biochem Behav. 1988, 31: 959-962. 10.1016/0091-3057(88)90413-3.CrossRefPubMed Treit D, Fundytus M: Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol Biochem Behav. 1988, 31: 959-962. 10.1016/0091-3057(88)90413-3.CrossRefPubMed
42.
43.
go back to reference Herzig MC: LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice. Hum Mol Genet. 2011, 40: 4209-4223.CrossRef Herzig MC: LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice. Hum Mol Genet. 2011, 40: 4209-4223.CrossRef
44.
go back to reference Tong Y, Giaime E, Yamaguchi H, Ichimura T, Liu Y, Si H, Cai H, Bonventre JV, Shen J: Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway. Mol Neurodegener. 2012, 7: 2-10.1186/1750-1326-7-2.PubMedCentralCrossRefPubMed Tong Y, Giaime E, Yamaguchi H, Ichimura T, Liu Y, Si H, Cai H, Bonventre JV, Shen J: Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway. Mol Neurodegener. 2012, 7: 2-10.1186/1750-1326-7-2.PubMedCentralCrossRefPubMed
45.
go back to reference Wahlsten D, Metten P, Phillips TJ, Boehm SL, Burkhart-Kasch S, Dorow J, Doerksen S, Downing C, Fogarty J, Rodd-Henricks K, Hen R, McKinnon CS, Merrill CM, Nolte C, Schalomon M, Schlumbohm JP, Sibert JR, Wenger CD, Dudek BC, Crabbe JC: Different data from different labs: lessons from studies of gene-environment interaction. J Neurobiol. 2003, 54: 283-311. 10.1002/neu.10173.CrossRefPubMed Wahlsten D, Metten P, Phillips TJ, Boehm SL, Burkhart-Kasch S, Dorow J, Doerksen S, Downing C, Fogarty J, Rodd-Henricks K, Hen R, McKinnon CS, Merrill CM, Nolte C, Schalomon M, Schlumbohm JP, Sibert JR, Wenger CD, Dudek BC, Crabbe JC: Different data from different labs: lessons from studies of gene-environment interaction. J Neurobiol. 2003, 54: 283-311. 10.1002/neu.10173.CrossRefPubMed
46.
go back to reference Lipp HP, Wolfer DP: Genetically modified mice and cognition. Curr Opin Neurobiol. 1998, 8: 272-280. 10.1016/S0959-4388(98)80151-7.CrossRefPubMed Lipp HP, Wolfer DP: Genetically modified mice and cognition. Curr Opin Neurobiol. 1998, 8: 272-280. 10.1016/S0959-4388(98)80151-7.CrossRefPubMed
47.
go back to reference Melrose HL, et al: Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice. Neurobiol Dis. 2010, 40: 503-517. 10.1016/j.nbd.2010.07.010.PubMedCentralCrossRefPubMed Melrose HL, et al: Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice. Neurobiol Dis. 2010, 40: 503-517. 10.1016/j.nbd.2010.07.010.PubMedCentralCrossRefPubMed
48.
go back to reference Hyde LA, Crnic LS, Pollock A, Bickford PC: Motor learning in Ts65Dn mice, a model for Down syndrome. Dev Psychobiol. 2001, 38: 33-45. 10.1002/1098-2302(2001)38:1<33::AID-DEV3>3.0.CO;2-0.CrossRefPubMed Hyde LA, Crnic LS, Pollock A, Bickford PC: Motor learning in Ts65Dn mice, a model for Down syndrome. Dev Psychobiol. 2001, 38: 33-45. 10.1002/1098-2302(2001)38:1<33::AID-DEV3>3.0.CO;2-0.CrossRefPubMed
49.
go back to reference Gerlai R, Pisacane P, Erickson S: Heregulin, but not ErbB2 or ErbB3, heterozygous mutant mice exhibit hyperactivity in multiple behavioral tasks. Behav Brain Res. 2000, 109: 219-227. 10.1016/S0166-4328(99)00175-8.CrossRefPubMed Gerlai R, Pisacane P, Erickson S: Heregulin, but not ErbB2 or ErbB3, heterozygous mutant mice exhibit hyperactivity in multiple behavioral tasks. Behav Brain Res. 2000, 109: 219-227. 10.1016/S0166-4328(99)00175-8.CrossRefPubMed
50.
go back to reference Vitali R, Clarke S: Improved rotorod performance and hyperactivity in mice deficient in a protein repair methyltransferase. Behav Brain Res. 2004, 153: 129-141. 10.1016/j.bbr.2003.11.007.CrossRefPubMed Vitali R, Clarke S: Improved rotorod performance and hyperactivity in mice deficient in a protein repair methyltransferase. Behav Brain Res. 2004, 153: 129-141. 10.1016/j.bbr.2003.11.007.CrossRefPubMed
51.
go back to reference Clabough EB, Zeitlin SO: Deletion of the triplet repeat encoding polyglutamine within the mouse Huntington's disease gene results in subtle behavioral/motor phenotypes in vivo and elevated levels of ATP with cellular senescence in vitro. Hum Mol Genet. 2006, 15: 607-623. 10.1093/hmg/ddi477.CrossRefPubMed Clabough EB, Zeitlin SO: Deletion of the triplet repeat encoding polyglutamine within the mouse Huntington's disease gene results in subtle behavioral/motor phenotypes in vivo and elevated levels of ATP with cellular senescence in vitro. Hum Mol Genet. 2006, 15: 607-623. 10.1093/hmg/ddi477.CrossRefPubMed
52.
go back to reference Sahay A, Drew MR, Hen R: Dentate gyrus neurogenesis and depression. Prog Brain Res. 2007, 163: 697-722.CrossRefPubMed Sahay A, Drew MR, Hen R: Dentate gyrus neurogenesis and depression. Prog Brain Res. 2007, 163: 697-722.CrossRefPubMed
53.
go back to reference Sahay A, Hen R: Adult hippocampal neurogenesis in depression. Nat Neurosci. 2007, 10: 1110-1115. 10.1038/nn1969.CrossRefPubMed Sahay A, Hen R: Adult hippocampal neurogenesis in depression. Nat Neurosci. 2007, 10: 1110-1115. 10.1038/nn1969.CrossRefPubMed
54.
go back to reference Kontgen F, Suss G, Stewart C, Steinmetz M, Bluethmann H: Targeted disruption of the MHC class II Aa gene in C57BL/6 mice. Int Immunol. 1993, 5: 957-964. 10.1093/intimm/5.8.957.CrossRefPubMed Kontgen F, Suss G, Stewart C, Steinmetz M, Bluethmann H: Targeted disruption of the MHC class II Aa gene in C57BL/6 mice. Int Immunol. 1993, 5: 957-964. 10.1093/intimm/5.8.957.CrossRefPubMed
55.
go back to reference Paxinos G, Franklin K: The Mouse Brain in Stereotaxic Coordinates. 2001, San Diego: Academic, 2 Paxinos G, Franklin K: The Mouse Brain in Stereotaxic Coordinates. 2001, San Diego: Academic, 2
56.
go back to reference Wolfer DP, Madani R, Valenti P, Lipp HP: Extended analysis of path data from mutant mice using the public domain software Wintrack. Physiol Behav. 2001, 73: 745-753. 10.1016/S0031-9384(01)00531-5.CrossRefPubMed Wolfer DP, Madani R, Valenti P, Lipp HP: Extended analysis of path data from mutant mice using the public domain software Wintrack. Physiol Behav. 2001, 73: 745-753. 10.1016/S0031-9384(01)00531-5.CrossRefPubMed
57.
go back to reference Kale A, Amende I, Meyer GP, Crabbe JC, Hampton TG: Ethanol's effects on gait dynamics in mice investigated by ventral plane videography. Alcohol Clin Exp Res. 2004, 28: 1839-1848. 10.1097/01.ALC.0000148103.09378.81.CrossRefPubMed Kale A, Amende I, Meyer GP, Crabbe JC, Hampton TG: Ethanol's effects on gait dynamics in mice investigated by ventral plane videography. Alcohol Clin Exp Res. 2004, 28: 1839-1848. 10.1097/01.ALC.0000148103.09378.81.CrossRefPubMed
58.
go back to reference Amende I, Kale A, McCue S, Glazier S, Morgan JP, Hampton TG: Gait dynamics in mouse models of Parkinson's disease and Huntington's disease. J Neuroeng Rehabil. 2005, 2: 20-10.1186/1743-0003-2-20.PubMedCentralCrossRefPubMed Amende I, Kale A, McCue S, Glazier S, Morgan JP, Hampton TG: Gait dynamics in mouse models of Parkinson's disease and Huntington's disease. J Neuroeng Rehabil. 2005, 2: 20-10.1186/1743-0003-2-20.PubMedCentralCrossRefPubMed
59.
go back to reference Goldberg NR, Hampton T, McCue S, Kale A, Meshul CK: Profiling changes in gait dynamics resulting from progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigrostriatal lesioning. J Neurosci Res. 2011, 89: 1698-1706. 10.1002/jnr.22699.CrossRefPubMed Goldberg NR, Hampton T, McCue S, Kale A, Meshul CK: Profiling changes in gait dynamics resulting from progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigrostriatal lesioning. J Neurosci Res. 2011, 89: 1698-1706. 10.1002/jnr.22699.CrossRefPubMed
60.
go back to reference Hamers FP, Lankhorst AJ, van Laar TJ, Veldhuis WB, Gispen WH: Automated quantitative gait analysis during overground locomotion in the rat: its application to spinal cord contusion and transection injuries. J Neurotrauma. 2001, 18: 187-201. 10.1089/08977150150502613.CrossRefPubMed Hamers FP, Lankhorst AJ, van Laar TJ, Veldhuis WB, Gispen WH: Automated quantitative gait analysis during overground locomotion in the rat: its application to spinal cord contusion and transection injuries. J Neurotrauma. 2001, 18: 187-201. 10.1089/08977150150502613.CrossRefPubMed
61.
go back to reference Morel P, Fauconneau B, Page G, Mirbeau T, Huguet F: Inhibitory effects of ascorbic acid on dopamine uptake by rat striatal synaptosomes: relationship to lipid peroxidation and oxidation of protein sulfhydryl groups. Neurosci Res. 1998, 32: 171-179. 10.1016/S0168-0102(98)00080-7.CrossRefPubMed Morel P, Fauconneau B, Page G, Mirbeau T, Huguet F: Inhibitory effects of ascorbic acid on dopamine uptake by rat striatal synaptosomes: relationship to lipid peroxidation and oxidation of protein sulfhydryl groups. Neurosci Res. 1998, 32: 171-179. 10.1016/S0168-0102(98)00080-7.CrossRefPubMed
62.
go back to reference Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976, 72: 248-254. 10.1016/0003-2697(76)90527-3.CrossRefPubMed Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976, 72: 248-254. 10.1016/0003-2697(76)90527-3.CrossRefPubMed
63.
go back to reference Moron JA, Perez V, Fernandez-Alvarez E, Marco JL, Unzeta M: "In vitro" effect of some 5-hydroxy-indolalkylamine derivatives on monoamine uptake system. J Neural Transm Suppl. 1998, 52: 343-349. 10.1007/978-3-7091-6499-0_37.CrossRefPubMed Moron JA, Perez V, Fernandez-Alvarez E, Marco JL, Unzeta M: "In vitro" effect of some 5-hydroxy-indolalkylamine derivatives on monoamine uptake system. J Neural Transm Suppl. 1998, 52: 343-349. 10.1007/978-3-7091-6499-0_37.CrossRefPubMed
Metadata
Title
LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors
Authors
Kelly M Hinkle
Mei Yue
Bahareh Behrouz
Justus C Dächsel
Sarah J Lincoln
Erin E Bowles
Joel E Beevers
Brittany Dugger
Beate Winner
Iryna Prots
Caroline B Kent
Kenya Nishioka
Wen-Lang Lin
Dennis W Dickson
Christopher J Janus
Matthew J Farrer
Heather L Melrose
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Molecular Neurodegeneration / Issue 1/2012
Electronic ISSN: 1750-1326
DOI
https://doi.org/10.1186/1750-1326-7-25

Other articles of this Issue 1/2012

Molecular Neurodegeneration 1/2012 Go to the issue